UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Ardelyx
ARDX
$992M
| $3M | ﹤0.01% |
435,962
-43,444
| -9% | -$256K |
|
1802
Argan
AGX
$8.3B
| $3M | ﹤0.01% |
29,570
-6,406
| -18% | -$507K |
|
|
VSXY
1803
Victoria's Secret
VSXY
$8.08B
| $2.99M | ﹤0.01% |
116,535
-26,247
| -18% | -$556K |
|
1804
Fomento Económico Mexicano
FMX
$41.2B
| $2.99M | ﹤0.01% |
30,335
+607
| +2% | +$65.4K |
|
1805
International Seaways
INSW
$4.57B
| $2.99M | ﹤0.01% |
58,035
-9,925
| -15% | -$523K |
|
1806
Cannae Holdings
CNNE
$640M
| $2.99M | ﹤0.01% |
156,844
-23,369
| -13% | -$449K |
|
|
EVRI
1807
DELISTED
Everi Holdings
EVRI
| $2.99M | ﹤0.01% |
227,186
-17,553
| -7% | -$207K |
|
1808
Lakeland Financial Corp
LKFN
$1.51B
| $2.98M | ﹤0.01% |
45,724
-6,985
| -13% | -$455K |
|
1809
National Healthcare
NHC
$3.39B
| $2.97M | ﹤0.01% |
23,608
-4,216
| -15% | -$530K |
|
1810
Melco Resorts & Entertainment
MLCO
$2.14B
| $2.96M | ﹤0.01% |
380,372
+178,993
| +89% | +$1.06M |
|
1811
BioCryst Pharmaceuticals
BCRX
$2.46B
| $2.96M | ﹤0.01% |
389,530
-43,373
| -10% | -$330K |
|
1812
Tilray
TLRY
$597M
| $2.95M | ﹤0.01% |
167,790
+10,753
| +7% | +$194K |
|
1813
Leonardo DRS
DRS
$12B
| $2.95M | ﹤0.01% |
104,577
-6,327
| -6% | -$174K |
|
1814
NexGen Energy
NXE
$6.9B
| $2.95M | ﹤0.01% |
451,358
+10,545
| +2% | +$65.5K |
|
1815
iShares Biotechnology ETF
IBB
$9.81B
| $2.94M | ﹤0.01% |
+20,200
| New | +$2.92M |
|
1816
Keros Therapeutics
KROS
$214M
| $2.94M | ﹤0.01% |
50,552
+2,271
| +5% | +$112K |
|
|
PWSC
1817
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $2.93M | ﹤0.01% |
128,636
-6,790
| -5% | -$154K |
|
1818
JELD-WEN Holding
JELD
$161M
| $2.93M | ﹤0.01% |
185,259
-9,210
| -5% | -$135K |
|
1819
Helios Technologies
HLIO
$2.69B
| $2.93M | ﹤0.01% |
61,352
-5,779
| -9% | -$254K |
|
1820
Papa John's
PZZA
$772M
| $2.92M | ﹤0.01% |
54,272
-7,707
| -12% | -$355K |
|
1821
Acadia Pharmaceuticals
ACAD
$5.07B
| $2.92M | ﹤0.01% |
189,739
-27,856
| -13% | -$465K |
|
1822
DNOW Inc
DNOW
$3.05B
| $2.91M | ﹤0.01% |
225,301
-44,836
| -17% | -$592K |
|
1823
Unitil
UTL
$969M
| $2.91M | ﹤0.01% |
48,081
-2,043
| -4% | -$119K |
|
1824
Ameresco
AMRC
$1.32B
| $2.9M | ﹤0.01% |
76,557
-8,674
| -10% | -$268K |
|
1825
Mercury Insurance
MCY
$5.94B
| $2.9M | ﹤0.01% |
46,060
-5,913
| -11% | -$351K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.